The government is launching an experimental program to ease the burden on caregivers of people with Alzheimer’s. The idea is to keep patients healthier without exhausting their families.
Alzheimer’s
Posted inNPR
FDA approves a second Alzheimer’s drug that can modestly slow disease
The approval of Eli Lilly’s Kisunla provides a new option for patients in the early stages of the incurable, memory-destroying ailment.
Posted inNPR
FDA advisors strongly back new Alzheimer’s drug, despite risks and limitations
Advisors to the Food and Drug Administration have recommended unanimously that the agency approve the Alzheimer’s drug donanemab.
Posted inNPR
Recent gaffes by Biden and Trump may be signs of normal aging — or may be nothing
President Biden and former President Trump have both experienced public memory lapses. But brain experts say such slips, on their own, are not a cause for concern.
